| Japanese |
|---|
| Title | 蛋白漏出性胃腸症における99mTc-DTPA-HSA scintigraphyの有用性の検討 - 99mTc-HSAとの対比 - |
|---|
| Subtitle | 《症例報告》 |
|---|
| Authors | 佐藤友保*, 中西敏夫**, 谷口金吾**, 伊藤勝陽* |
|---|
| Authors(kana) | |
|---|
| Organization | *広島大学医学部放射線医学教室, **広島大学医学部附属病院放射線部 |
|---|
| Journal | 核医学 |
|---|
| Volume | 33 |
|---|
| Number | 10 |
|---|
| Page | 1091-1095 |
|---|
| Year/Month | 1996/10 |
|---|
| Article | 報告 |
|---|
| Publisher | 日本核医学会 |
|---|
| Abstract | 「要旨」臨床的に蛋白漏出が疑われた炎症性腸疾患症例3例を対象に, 99mTc-diethylenetriaminepentaacetic acid human serum albuminシンチグラム(以下HSADと略)と99mTc-human serum albuminシンチグラム(以下HSAと略)を同時期に施行し, 有用性を比較検討した. HSADは, HSAに比しバックグラウンドが低く早期からの腸管描出が得られ, より鋭敏な検査法であると思われた. HSAでは腎が, HSADでは肝が強く描出された. 特にHSAでの腎描出は腸管との重なりが多く, 読影はHSADが容易であった. 以上より, HSADシンチは, 蛋白漏出性胃腸症の診断に有用な検査法の一つであると考えられた. 「I. 緒言」蛋白漏出性胃腸症(以下PLEと略)の蛋白漏出の判定, 漏出部位の同定に99mTc-human serum albumin(人血清アルブミン)シンチグラム(以下HSAと略)が有効であることは, われわれもすでに検討し報告した. |
|---|
| Practice | 臨床医学：一般 |
|---|
| Keywords | 99mTc-DTPA-HSA, 99mTc-HSA, Protein losing enteropathy, Inflammatory bowel disease. |
|---|
| English |
|---|
| Title | Usefulness of 99mTc-DTPA-HSA Scintigraphy in the Diagnosis of Protein Losing Enteropathy - Comparison with 99mTc-HSA - |
|---|
| Subtitle | - Case Report - |
|---|
| Authors | Tomoyasu SATO*, Toshio NAKANISHI**, Kingo TANIGUCHI**, Katsuhide ITO* |
|---|
| Authors(kana) | |
|---|
| Organization | *Department of Radiology, **Department of Clinical Radiology, Hiroshima University School of Medicine |
|---|
| Journal | The Japanese Journal of nuclear medicine |
|---|
| Volume | 33 |
|---|
| Number | 10 |
|---|
| Page | 1091-1095 |
|---|
| Year/Month | 1996/10 |
|---|
| Article | Report |
|---|
| Publisher | THE JAPANESE SOCIETY OF NUCLEAR MEDICINE |
|---|
| Abstract | We evaluated the usefulness of 99mTc-diethylenetriamine-pentaacetic acid human serum albumin scintigraphy (FTPA-HSA) in the diagnosis of protein losing enteropathy in 3 cases of inflammatory bowel diseases in comparison with 99Tc-human serum albumin scintigraphy (HSA). The results were as follows; 1. DTPA-HSA demonstrated the colonic accumulation earlier than that of HSA. 2. Hepatic flexure and splenic flexure are not observed clearly, because of marked renal uptake in HSA. On the other hand, they are observed in DTPA-HSA. Hepatic uptake is rather stronger in DTPA-HSA. In conclusion, DTPA-HSA is one of the easiest and most useful methods in the diagnosis of protein losing enteropathy. |
|---|
| Practice | Clinical medicine |
|---|
| Keywords | 99mTc-DTPA-HSA, 99mTc-HSA, Protein losing enteropathy, Inflammatory bowel disease. |
|---|